Adma Biologics reported $296.93M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adamis Pharmaceuticals ADMP:US 17.69M 12.85M
Adma Biologics ADMA:US $ 296.93M 11.1M
Agile Therapeutics AGRX:US $ 32.83M 3.53M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Biocryst Pharmaceuticals BCRX:US $ 510.54M 17.18M
Dynavax Technologies DVAX:US $ 1023M 14.02M
Minerva Neurosciences NERV:US $ 64.96M 5.66M
Novavax NVAX:US $ 2622.99M 211.88M
Omeros OMER:US $ 345.64M 23.62M
Takeda 4502:JP Y 14065426M 887408M